ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2313

Patients with Rheumatoid Arthritis Have a Higher Risk of Bipolar Disorder: A Systematic Review and Meta-analysis

Patompong Ungprasert1, Nipith Charoenngam 2 and Ben Ponvilawan 2, 1Cleveland Clinic, Cleveland, OH, Bangkok, Thailand, 2Mahidol University, Bangkok, Thailand

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: Comorbidity, Epidemiologic methods, neuropsychiatric disorders and meta-analysis, Rheumatoid arthritis (RA)

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 12, 2019

Title: RA – Diagnosis, Manifestations, & Outcomes Poster III: Comorbidities

Session Type: Poster Session (Tuesday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Patients with chronic autoimmune diseases may have a higher risk of psychiatric illness as a result of chronic neuro-inflammation and immune dysregulation. The current study was conducted with the aim to investigate the relationship between rheumatoid arthritis (RA) and bipolar disorder by identifying all available studies and summarizing their results together.

Methods: Potentially eligible studies that compared the risk of developing bipolar disorder between patients with RA and individuals without RA were identified from Medline and EMBASE databases from inception to May 2019 using search strategy that comprised of terms for “rheumatoid arthritis” and “bipolar disorder”.  Eligible studies could be either cohort studies or case-control studies.  For cohort studies, they must recruit two groups of participants, patients with RA and individuals without RA.  Then, the studies must follow their participants for incident bipolar disorder and report relative risk between the two groups.  For case-control studies, they must recruit cases with bipolar disorder and controls without bipolar disorder.  Then, the studies must explore their prior history of RA and report odds ratio comparing the two groups.  Relative risk and standard error from each study were extracted and combined together using the random effect, generic inverse variance technique of DerSimonian and Laird.  Odds ratio of case-control study was used as an estimate for relative risk to calculate the pooled effect estimate along with relative risk of cohort study.

Results: A total of 1,542 articles were identified using the aforementioned search strategy.  After two rounds of independent review by two investigators, six studies with 420,458 participants fulfilled the inclusion criteria and were included into the meta-analysis. The risk of developing bipolar disorder was significantly higher among patients with RA than individuals without RA with the pooled relative risk of 2.06 (95% CI, 1.34 – 3.17; I2 86%) (figure 1).  Funnel plot was relatively symmetric and was not suggestive of presence of publication bias (figure 2).

Conclusion: A significantly higher risk of developing bipolar disorder among patients with RA was demonstrated in this study.

Figure 1: Forest plot of the current meta-analysis

Figure 2: Funnel plot of the current meta-analysis


Disclosure: P. Ungprasert, None; N. Charoenngam, None; B. Ponvilawan, None.

To cite this abstract in AMA style:

Ungprasert P, Charoenngam N, Ponvilawan B. Patients with Rheumatoid Arthritis Have a Higher Risk of Bipolar Disorder: A Systematic Review and Meta-analysis [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/patients-with-rheumatoid-arthritis-have-a-higher-risk-of-bipolar-disorder-a-systematic-review-and-meta-analysis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/patients-with-rheumatoid-arthritis-have-a-higher-risk-of-bipolar-disorder-a-systematic-review-and-meta-analysis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology